Seeking Alpha

More on BD fiscal Q2 results

  • Revenues: $2.072B (+3.6%), Medical: $1.116B (+5.1%), Diagnostics: $653M (+0.9%), Biosciences: $302M (+8.2%).
  • EPS: $1.45 (+4.3%).
  • Updated F14 guidance:
  • Revenue growth: 4% - 4.5%.
  • EPS: $6.14 - $6.17, down from $6.19 - $6.22.
  • (BDX)

Check out Seeking Alpha’s new Earnings Center »

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs